BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 1214504)

  • 1. Protein content of liver lymph in patients with portal hypertension secondary to hepatic cirrhosis.
    Dumont AE; Witte CL; Witte MH
    Lymphology; 1975 Dec; 8(4):111-3. PubMed ID: 1214504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual origin of ascites in hepatic cirrhosis.
    Witte CL; Witte MH; Cole WR; Chung YC; Bleisch VR; Dumont AE
    Surg Gynecol Obstet; 1969 Nov; 129(5):1027-33. PubMed ID: 5824266
    [No Abstract]   [Full Text] [Related]  

  • 3. Theoretical and practical considerations in the treatment of portal hypertension secondary to hepatic cirrhosis.
    Bizer LS
    Am Surg; 1984 Oct; 50(10):524-9. PubMed ID: 6385791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatic blood flow, portal hypertension and liver failure in patients with alcoholic cirrhosis (author's transl)].
    Lebrec D; Sicot C; Benhamou JP
    Arch Fr Mal App Dig; 1973 Sep; 62(6):465-71. PubMed ID: 4779228
    [No Abstract]   [Full Text] [Related]  

  • 5. [Physiopathology of portal hypertension in liver cirrhosis].
    Cervela LA
    Rev Esp Enferm Apar Dig; 1973 Jan; 39(2):223-38. PubMed ID: 4690385
    [No Abstract]   [Full Text] [Related]  

  • 6. Colloid osmotic pressure in hepatic cirrhosis and experimental ascites.
    Witte CL; Witte MH; Kintner K; Cole WR; Dumont AE
    Surg Gynecol Obstet; 1971 Jul; 133(1):65-71. PubMed ID: 5091826
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulation of sinusoidal perfusion in portal hypertension.
    Reynaert H; Urbain D; Geerts A
    Anat Rec (Hoboken); 2008 Jun; 291(6):693-8. PubMed ID: 18484616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
    Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanism of development of portal hypertension in liver cirrhosis].
    Kalashnikov SA
    Klin Med (Mosk); 1975 Apr; 53(4):74-8. PubMed ID: 1152376
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cirrhosis of the liver without portal hypertension (author's transl)].
    Cortinovis A; Crippa A; Bellorini R
    Chir Ital; 1980 Oct; 32(5):996-1005. PubMed ID: 7249193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etiology and pathophysiology of portal hypertension.
    Reichen J
    Z Gastroenterol; 1988 Sep; 26 Suppl 2():3-7. PubMed ID: 3055716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective plasma oncotic pressure in hepatic cirrhosis and experimental ascites.
    Witte CL; Witte MH; Cole WR; Dumont AE
    Surg Forum; 1969; 20():378-80. PubMed ID: 5383090
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatic localization of endothelin-1 in patients with idiopathic portal hypertension and cirrhosis of the liver.
    Kamath PS; Carpenter HA; Lloyd RV; McKusick MA; Steers JL; Nagorney DM; Miller VM
    Liver Transpl; 2000 Sep; 6(5):596-602. PubMed ID: 10980059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of increased intraabdominal pressure on hepatic hemodynamics in patients with chronic liver disease and portal hypertension.
    Iwatsuki S; Reynolds TB
    Gastroenterology; 1973 Aug; 65(2):294-9. PubMed ID: 4720031
    [No Abstract]   [Full Text] [Related]  

  • 15. Lymph circulation in hepatic cirrhosis: effect of portacaval shunt.
    Witte MH; Dumont AE; Cole WR; Witte CL; Kintner K
    Ann Intern Med; 1969 Feb; 70(2):303-10. PubMed ID: 5764506
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis.
    Schneider AW; Kalk JF; Klein CP
    Hepatology; 1999 Feb; 29(2):334-9. PubMed ID: 9918907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of distal splenocaval shunt on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension].
    Cai JX
    Zhonghua Wai Ke Za Zhi; 1991 Jul; 29(7):426-8, 462. PubMed ID: 1813226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preoperative evaluation of hemodynamics and the functional state of the liver in cirrhosis].
    Anisimova SM
    Vestn Khir Im I I Grek; 1972 Dec; 109(12):32-5. PubMed ID: 4664077
    [No Abstract]   [Full Text] [Related]  

  • 19. Vascular deterioration in cirrhosis: the big picture.
    Bosch J
    J Clin Gastroenterol; 2007; 41 Suppl 3():S247-53. PubMed ID: 17975472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemodynamic interrelations in portal hypertension caused by hepatic cirrhosis].
    Garcia Civera R; Benages Martínez A; Lopez Merino F; Garcia-Conde Gomez FJ
    Rev Esp Enferm Apar Dig; 1972 Jul; 38(1):19-34. PubMed ID: 5069488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.